Abstract:Background Quantitative susceptibility mapping (QSM) is a quantitative measure based on magnetic resonance imaging sensitive to iron and myelin content. This makes QSM a promising non-invasive tool for multiple sclerosis (MS) in research and clinical practice. Objective We performed a systematic review and meta-analysis on the use of QSM in MS. Methods Our review was prospectively registered on PROSPERO (CRD42022309563). We searched five databases for studies published between inception and 30th April 2023. We identified 83 English peer-reviewed studies that applied QSM images on MS cohorts. Fifty-five included studies had at least one of the following outcome measures: deep grey matter QSM values in MS, either compared to healthy controls (HC) (k = 13) or correlated with the score on the Expanded Disability Status Scale (EDSS) (k = 7), QSM lesion characteristics (k = 22) and their clinical correlates (k = 17), longitudinal correlates (k = 11), histological correlates (k = 7), or correlates with other imaging techniques (k = 12). Two meta-analyses on deep grey matter (DGM) susceptibility data were performed, while the remaining findings could only be analyzed descriptively. Results After outlier removal, meta-analyses demonstrated a significant increase in the basal ganglia susceptibility (QSM values) in MS compared to HC, caudate (k = 9, standardized mean difference (SDM) = 0.54, 95 % CI = 0.39–0.70, I 2 = 46 %), putamen (k = 9, SDM = 0.38, 95 % CI = 0.19–0.57, I 2 = 59 %), and globus pallidus (k = 9, SDM = 0.48, 95 % CI = 0.28–0.67, I 2 = 60 %), whereas thalamic QSM values exhibited a significant reduction (k = 12, SDM = −0.39, 95 % CI = −0.66–−0.12, I 2 = 84 %); these susceptibility differences in MS were independent of age. Further, putamen QSM values positively correlated with EDSS (k = 4, r = 0.36, 95 % CI = 0.16–0.53, I 2 = 0 %). Regarding rim lesions, four out of seven studies, representing 73 % of all patients, reported rim lesions to be associated with more severe disability. Moreover, lesion development from initial detection to the inactive stage is paralleled by increasing, plateauing (after about two years), and gradually decreasing QSM values, respectively. Only one longitudinal study provided clinical outcome measures and found no association. Histological data suggest iron content to be the primary source of QSM values in DGM and at the edges of rim lesions; further, when also considering data from myelin water imaging, the decrease of myelin is likely to drive the increase of QSM values within WM lesions Conclusions We could provide meta-analytic evidence for DGM susceptibility changes in MS compared to HC; basal ganglia susceptibility is increased and, in the putamen, associated with disability, while thalamic susceptibility is decreased. Beyond these findings, further investigations are necessary to establish the role of QSM in MS for research or even clinical routine.

Clinical Feasibility of Brain Quantitative Susceptibility Mapping.

Cerebral Microbleeds: Burden Assessment by Using Quantitative Susceptibility Mapping

Clinical Quantitative Susceptibility Mapping (QSM): Biometal Imaging and Its Emerging Roles in Patient Care

Abstract WP292: Quantitative Susceptibility Mapping for Reliably Measuring Hematoma Volume in Magnetic Resonance Imaging

Hematoma Volume Measurement in Gradient Echo MRI Using Quantitative Susceptibility Mapping.

MEDI+0: Morphology Enabled Dipole Inversion with Automatic Uniform Cerebrospinal Fluid Zero Reference for Quantitative Susceptibility Mapping

Quantitative Susceptibility Mapping As a Biomarker for Evaluating White Matter Alterations in Parkinson's Disease.

MoG-QSM: Model-based Generative Adversarial Deep Learning Network for Quantitative Susceptibility Mapping.

Recommended Implementation of Quantitative Susceptibility Mapping for Clinical Research in The Brain: A Consensus of the ISMRM Electro-Magnetic Tissue Properties Study Group

Feasibility of submillimeter functional quantitative susceptibility mapping using 3D echo planar imaging at 7 T

CSF Susceptibility Variation in Patient With Intracranial Hemorrhage: Implications for Quantitative Susceptibility Mapping Reference Selection

Quantitative susceptibility mapping in multiple sclerosis: A systematic review and meta-analysis

Improving quantitative susceptibility mapping for the identification of traumatic brain injury neurodegeneration at the individual level

Automated Quantitative Susceptibility and Morphometry MR Study: Feasibility and Interrelation Between Clinical Score, Lesion Load, Deep Grey Matter and Normal-Appearing White Matter in Multiple Sclerosis

Quantitative susceptibility mapping (QSM) as a means to monitor cerebral hematoma treatment.

Recommended implementation of quantitative susceptibility mapping for clinical research in the brain: A consensus of the ISMRM electro‐magnetic tissue properties study group

Learning-based single-step quantitative susceptibility mapping reconstruction without brain extraction

Quantitative susceptibility mapping evaluation of glioma

Quantitative susceptibility mapping analyses of white matter in Parkinson's disease using susceptibility separation technique

Three‐dimensional EPI with shot‐selective CAIPIRIHANA for rapid high‐resolution quantitative susceptibility mapping at 3 T

Deep grey matter quantitative susceptibility mapping from small spatial coverages using deep learning